

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Tisagenlecleucel mushonga wekenza unovhura nzira itsva unoshandisa maseru ako emuviri ekudzivirira chirwere kurwisa mamwe marudzi ekenza yeropa. Mushonga uyu unogadzira zvinhu zvitsva, unozivikanwawo seCAR-T cell therapy, unotora maT-cells ako (rudzi rwechena yeropa), anovagadzirisa murabhoritari kuti vazive zviri nani uye kurwisa maseru ekenza, wobva wavaisa mumuviri wako.
Mushonga uyu unomiririra kufambira mberi kukuru mukuchengetwa kwekenza kwemunhu. Kusiyana nechemotherapy yechinyakare iyo inokanganisa maseru ese anokurumidza kukamukana, tisagenlecleucel inonyanya kutarisisa maseru ekenza ichisiya maseru ane hutano asina kubatwa zvakanyanya.
Tisagenlecleucel inorapa marudzi akasiyana ekenza yeropa kana mamwe marapirwo asina kushanda kana kana kenza yakadzoka. Chiremba wako anowanzo funga nezvemushonga uyu kana wakaedza nzira dzekurapa dzinenge mbiri dzisina kubudirira.
Mishonga iyi inobvumirwa kurapa acute lymphoblastic leukemia (ALL) muvana nevechidiki vane makore makumi maviri nemashanu. ALL ikenza inokurumidza kukura inokanganisa maseru machena eropa, zvichiita kuti muviri wako urwise zvirwere uye kudzora kubuda ropa.
Inoshandiswawo kune mamwe marudzi e-large B-cell lymphoma muvanhu vakuru. Izvi zvinosanganisira diffuse large B-cell lymphoma uye mamwe malymphomas ane hukama ayo akadzoka mushure mekurapwa kana asina kupindura kune mamwe marapirwo apfuura.
Mushonga uyu unoshanda nekushandura muviri wako wekudzivirira chirwere kuita simba guru rekurwisa kenza. Maitiro acho anotanga apo vanachiremba vanounganidza maT-cells ako kuburikidza nemaitiro akafanana nekupa ropa.
Murabhoritari, masayendisiti anogadzirisa maseru aya nekuwedzera receptor yakakosha inonzi chimeric antigen receptor (CAR). Iyi receptor inoshanda seGPS system, ichibatsira maT-cells ako kuwana uye kuvhara pane protein yakati wandei inowanikwa pamasero ekenza anonzi CD19.
Kana masero akachinjwa aiswa mumuviri mako, anowanda uye anova anoshanda zvakanyanya pakuziva nekuparadza masero ekenza. Funga nezvazvo sekupa immune system yako kudzidziswa kwakakosha uye maturusi ekurwisa kenza zvakanyanya.
Izvi zvinoonekwa seimwe nzira yekurapa yakasimba uye yakashandiswa zvakanyanya. Kusiyana nechemotherapy yechinyakare, tisagenlecleucel inogadzira mhinduro inorarama, inoenderera mberi yeimmune iyo inogona kuramba ichishanda mumuviri wako kwemwedzi kana kunyange makore.
Tisagenlecleucel inopiwa seimwechete intravenous infusion panzvimbo yekurapa yakakosha. Hauzogoni kutora mushonga uyu kumba, uye zvinoda kugadzirira nekuchenjerera uye kuongororwa nechikwata chekurapa chakadzidziswa.
Usati wapiwa kurapwa, uchapfuura nekuita kunonzi leukapheresis kuti utore T-masero ako. Izvi zvinowanzo tora maawa 3-6 uye zvinosanganisira kubviswa kweropa kubva muruoko rumwe, kugadziriswa nemuchina unoparadzanisa T-masero, uye wobva wadzoserwa kune rimwe ruoko rwako.
Panguva iyo masero ako achigadziridzwa murabhoritari (iyo inotora anenge 3-4 mavhiki), unogona kugamuchira bridging chemotherapy kubatsira kudzora kenza yako. Chikwata chako chekurapa chichapa mirairo chaiyo yekudya, kunwa, uye chero mishonga yekudzivirira panguva ino.
Mazuva mashoma usati wapiwa infusion, uchagamuchira lymphodepleting chemotherapy kugadzirira muviri wako. Izvi zvinobatsira kugadzira nzvimbo yemaseru akachinjwa kuti akure uye ashande nemazvo.
Iyo chaiyo tisagenlecleucel infusion inotora anenge maminitsi makumi matatu-60. Uchaongororwa zvakanyanya muchipatara kwemazuva gumi mushure mekuiswa, sezvo iyi iri nguva iyo mhedzisiro yakakomba inogona kuitika.
Tisagenlecleucel inopiwa sekurapa kamwe chete, kwete mushonga unoenderera mberi waunotora kakawanda. Kana masero akachinjwa aiswa mumuviri wako, akagadzirirwa kuramba achishanda kwenguva yakareba.
Masero eT akachinjwa anogona kuramba achishanda mumuviri mako kwemwedzi kana makore, achipa dziviriro inoramba ichirwisa masero ekenza. Vamwe varwere vakachengetedza remission kwemakore akati wandei mushure mekuwana kurapwa kumwe chete uku.
Zvisinei, chikwata chako chekurapa chichakutarisa zvakanyanya nekugadzwa kwenguva dzose uye bvunzo dzeropa. Izvi zvekutarisa zvinobatsira kuona kuti kurapwa kuri kushanda uye kutarisira chero mhedzisiro yakareba kana zviratidzo zvekenza zvichidzoka.
Nepo tisagenlecleucel ichigona kushanda zvakanyanya, inogona kukonzera mhedzisiro yakakomba inoda kutariswa kwekurapa nekukurumidza. Kunzwisisa izvi kunobatsira iwe nechikwata chako chekurapa kupindura nekukurumidza kana zvikaitika.
Mhedzisiro yakajairika uye yakakomba inoitika nekuti masero ako ekudzivirira akachinjwa anova anoshanda zvakanyanya mukurwisa kenza. Izvi dzimwe nguva zvinogona kukonzera mhinduro yekudzivirira muviri yakanyanya mumuviri wako wese.
Cytokine release syndrome (CRS) ndiyo mhedzisiro yakakosha yekutarisa. Izvi zvinowanikwa kana masero ako eT akashandiswa achiburitsa huwandu hukuru hwezvinhu zvinopisa zvinonzi cytokines. Zviratidzo zvekutanga zvinosanganisira:
CRS inogona kubva pakureruka kusvika kuhupenyu hunotyisa, ndosaka uchizotarisiswa zvakanyanya muchipatara. Chikwata chako chekurapa chine mishonga chaiyo uye kurapwa kwekugadzirisa iyi mamiriro zvinobudirira.
Neurologic side effects inogonawo kuitika, ichikanganisa uropi hwako uye tsinga dzako. Izvi zvinogona kusanganisira:
Mhedzisiro zhinji dzinokonzerwa nepfungwa dzinogona kupfuura uye dzinopera mukati memavhiki mashoma, kunyangwe dzimwe dzingatora nguva yakareba kuti dzinyangarike zvachose.
Dzimwe mhedzisiro yaungasangana nayo zvinosanganisira:
Mhedzisiro yenguva refu inogona kusanganisira immune system yakaderera, zvichikuita kuti utapukirwe zviri nyore. Chiremba wako achakurukura zvirongwa zvekudzivirira uye nzira dzekudzivirira kutapukirwa newe.
Zvisingawanzoitiki asi zvakakomba zvinogona kusanganisira kutapukirwa kwakanyanya, kenza yechipiri, kana kuverengwa kwemaseru eropa akaderera kwenguva yakareba. Chikwata chako chekurapa chichakutarisa zvakanyanya kuti uone zvingaitika izvi panguva yekutevera kwako.
Tisagenlecleucel haina kukodzera munhu wese, uye chikwata chako chekurapa chichaongorora zvakanyanya kana iwe uri munhu akakodzera kurapwa uku. Zvinhu zvakati wandei zvinogona kuita kuti kurapwa uku kusakodzere kana kuve nenjodzi yakanyanya.
Unogona kunge usina kukodzera kana uine hutachiona hunoshanda, husina kudzora. Muviri wako unofanirwa kuve mumamiriro akanaka ekugona kubata immune response yakasimba iyo tisagenlecleucel inogadzira.
Matambudziko akakomba emoyo, mapapu, chiropa, kana itsvo anogona kukuita kuti uve panjodzi yakanyanya yekurapwa uku. Mhedzisiro inogona kuisa kushushikana kwakawanda pamitezo iyi, saka inofanirwa kushanda zvakanaka kuti ikwanise kubata kurapwa.
Kana uine mamwe mamiriro eautoimmune, kurapwa uku hakungave kwakakodzera. Kurapa kunogona kuwedzera zvirwere zveautoimmune nekumwe kuita immune system yako.
Maitiro akakomba ekutanga ekurapa kwakafanana kana zvimwe zvikamu zvekurapa zvinogona zvakare kukubvisa kubva pakugamuchira tisagenlecleucel.
Chiremba wako achafungawo nezve hutano hwako hwese, zera rako, uye kuti ungashandisa sei zvakanaka kuongororwa kwakanyanya uye mhedzisiro inogona kuitika. Sarudzo iyi inosanganisira kuyera mabhenefiti anogona kuitika pamwe nenjodzi dzemamiriro ako chaiwo.
Tisagenlecleucel inotengeswa pasi pezita rebrand Kymriah. Zita rebrand iri rinoshandiswa pasi rose, zvichiita kuti zvive nyore kuti varwere nevashandi vehutano vazive iyi chaiyo CAR-T cell therapy.
Kymriah inogadzirwa neNovartis, kambani yemishonga yakagadzira kurapwa uku kunoshamisa. Paunonzwa zita ripi zvaro - tisagenlecleucel kana Kymriah - vanoreva mushonga mumwe chete.
Chikwata chako chekurapa chinogona kushandisa mazita ese ari maviri zvakachinjana, saka usavhiringike kana ukanzwa mazwi akasiyana achireva kurapwa kwako.
Mamwe maCAR-T cell therapies aripo, kunyangwe imwe neimwe ichitarisa mhando dzakasiyana dzekenza uye vanhu varwere. Zvimwe zvinhu izvi zvinoshanda zvakafanana ne tisagenlecleucel asi zvinogona kunge zvine mvumo dzakasiyana kana maprofiles emhedzisiro.
Axicabtagene ciloleucel (Yescarta) imwe CAR-T therapy yakatenderwa kune mamwe ma lymphomas muvanhu vakuru. Inotarisawo CD19 asi inogadziriswa zvakasiyana uye inogona kukodzera mapoka evarwere akasiyana.
Brexucabtagene autoleucel (Tecartus) inotenderwa kune mamwe marudzi e lymphoma uye leukemia. Kurapa uku kunotarisa iyo imwechete CD19 protein asi ine maitiro akasiyana ekugadzira.
Lisocabtagene maraleucel (Breyanzi) imwe sarudzo yeimwe lymphomas, yakagadzirirwa kukonzera mashoma akakomba mhedzisiro uchichengetedza kushanda.
Sarudzo dzekurapa dzechinyakare dzinogona kuramba dzichifungwa zvichienderana nemamiriro ako chaiwo. Izvi zvinosanganisira chemotherapy yechinyakare, radiation therapy, kana stem cell transplantation.
Chiremba wako wezve oncology achabatsira kuona kuti ndechipi chisarudzo chakanakira rudzi rwako rwekenza, hutano hwako hwese, uye nhoroondo yekurapa.
Kuenzanisa marapirwo eCAR-T hakuna kunanga nekuti imwe neimwe yakaedzwa mumapoka akasiyana evarwere uye marudzi ekenza. Chinhu chinonyanya kukosha kuwana kurapwa kwakakodzera kune mamiriro ako chaiwo.
Tisagenlecleucel yakaratidza mhedzisiro yakanaka muvana nevechidiki ALL, nevakawanda varwere vachiwana remission yakakwana. Iyo yakareba-nguva yekutevera-data inoramba ichiratidza mhedzisiro inovimbisa yeboka iri.
Kune vanhu vakuru vane lymphomas, akasiyana marapirwo eCAR-T anogona kunge akakodzera zvichienderana nerudzi rwe lymphoma uye nhoroondo yako yekurapa. Mamwe marapirwo anogona kunge aine zvishoma zvakasiyana side effect profiles kana kugadzira nguva.
Sarudzo
Kana uine matambudziko emoyo akapfava, unogona kunge uchiri kukodzera nekutarisa kwepedyo. Zvisinei, kukundikana kwemoyo kwakanyanya kana kurwisa kwemoyo kwemazuva ano kazhinji kunoita kuti kurapwa uku kuve kwakanyanya njodzi.
Tisagenlecleucel overdose haigoneki mupfungwa dzechinyakare nekuti inopiwa semadosi ega, akanyatsoverengwa nevanachiremba vakadzidziswa. Huwandu hwaunogamuchira hunonyatso tsanangurwa zvichienderana nehuremu hwemuviri wako uye kuverenga maseru.
Kana uine hanya nekurapwa kwako kana uchiona zviratidzo zvisingatarisirwi, taura nechikwata chako chekurapa nekukasira. Vanogona kuongorora kana zviratidzo zvako zvichibatanidzwa nemhedzisiro yakajairika yekurapa kana chimwe chinhu chinoda kupindira.
Chikwata chekurapa chinotevera mitemo yakasimba kuti chive nechokwadi chekuti unogamuchira dosi chaiyo, zvichiita kuti kukanganisa kwekuisa dosi kusaite.
Sezvo tisagenlecleucel ichipiwa seimwechete infusion, haugone chaizvo "kukanganwa" dosi sezvaungaita nemishonga yezuva nezuva. Zvisinei, kana infusion yako yakarongwa ikanonoka kana kumiswa, gara uchibatana zvakanyanya nechikwata chako chekurapa.
Kunonoka kurapwa kunogona kuitika nezvikonzero zvakasiyana-siyana, zvakadai senyaya dzekugadzira, hutachiona, kana shanduko muhutano hwako. Chikwata chako chekurapa chichashanda kuronga kurapwa kwako zvakare nekukurumidza sezvazvakachengeteka kuenderera mberi.
Panguva yekunonoka, unogona kugamuchira bridging therapy kubatsira kudzora kenza yako kusvikira tisagenlecleucel infusion ichipiwa.
Hau "mira kutora" tisagenlecleucel nekuti kurapwa kamwe chete, kwete mushonga unogara uripo. Kana maseru eT-akagadziridzwa ainge apiwa mumuviri wako, anoenderera mberi achishanda ega.
Zvinogona kutora mwedzi kana makore, uye vamwe varwere vanoramba vari muchirwere kwenguva yakareba mushure mekurapa kamwe chete. Chikwata chako chekurapa chichakutarisa nguva dzose kuti chione kuti kurapa kuri kushanda sei.
Kana kenza yako ikadzoka kana kurapa kusiri kushanda sezvaitarisirwa, chiremba wako achakurukura dzimwe nzira dzekurapa newe.
Chirongwa chako chejekiseni chichada kutarisirwa zvakanyatsonaka mushure mekurapa tisagenlecleucel. Kurapa kunogona kukanganisa kugona kwemuviri wako kupindura majekiseni uye kurwisa zvirwere.
Majekiseni mhenyu anowanzo dziviswa mushure meCAR-T therapy nekuti immune system yako inogona kukanganiswa. Chikwata chako chekurapa chichapa gwara rakajeka pamusoro pemajekiseni akachengeteka uye nguva yekuaona.
Vazhinji vanachiremba vanokurudzira kumirira angangoita mwedzi yakati wandei mushure mekurapa usati watora mamwe majekiseni, uye vamwe vanogona kuda kutarisa basa rako rekudzivirira zvirwere kutanga. Nguva dzose taura nechikwata chako chekurapa usati watora chero jekiseni.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.